Class I Graft-Versus-Host Mismatch Based on Predicted Indirectly Recognizable HLA Epitopes (PIRCHES) Is Associated with Worse Post-Transplant Outcomes in Patients Receiving Peripheral Blood, T-Cell Replete Haploidentical Hematopoietic Cell Transplantation with Post-Transplant Cyclophosphamide

被引：0
|
作者：
Rimando, Joseph [1 ]
Slade, Michael [2 ]
Gao, Feng [3 ]
Romee, Rizwan [4 ,5 ]
Liu, Chang [6 ]
机构：
[1] Washington Univ, Sch Med, Dept Med, St Louis, MO USA
[2] Washington Univ, Sch Med, Div Oncol, Bone Marrow Transplantat & Leukemia Sect, St Louis, MO USA
[3] Washington Univ, Sch Med, Dept Surg, Div Publ Hlth,Sci Sect Oncol Biostat, St Louis, MO 63110 USA
[4] Dana Farber Canc Inst, Dept Hematol Malignancies, Boston, MA 02115 USA
[5] Harvard Med Sch, Boston, MA 02115 USA
[6] Washington Univ, Sch Med, Pathol & Immunol, St Louis, MO USA
来源：
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION | 2019年 / 25卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
289
引用
收藏
页数：1
相关论文
共 50 条
  • [11] Reduced Dose of Post-Transplant Cyclophosphamide for HLA Haploidentical Peripheral Blood Stem Cell Transplantation
    Morishige, Satoshi
    Yamasaki, Yoshitaka
    Oya, Shuki
    Nakamura, Takayuki
    Ymaguchi, Maki
    Aoyama, Kazutoshi
    Seki, Ritsuko
    Mouri, Fumihiko
    Osaki, Koichi
    Nagafuji, Koji
    BLOOD, 2018, 132
  • [12] Reduced Post-Transplant Cyclophosphamide Doses in T-Cell Replete Haploidentical Hematopoietic Stem Cell Transplantation in Elderly Patients with Hematologic Malignancies
    Dulery, Remy
    Goudet, Claire
    Bianchessi, Antonio
    Granata, Angela
    Harbi, Samia
    Maisano, Valerio
    Chabannon, Christian
    Malard, Florent
    Brissot, Eolia
    Sestili, Simona
    Mediavilla, Clemence
    Banet, Anne
    Van de Wyngaert, Zoe
    Paviglianiti, Annalisa
    Belhocine, Ramdane
    Ederhy, Stephane
    Pagliardini, Thomas
    Legrand, Faezeh
    Castagna, Lucas
    Blaise, Didier
    Mohty, Mohamad
    Furst, Sabine
    Devillier, Raynier
    BONE MARROW TRANSPLANTATION, 2020, 55 (SUPPL 1) : 138 - 139
  • [13] Haploidentical Hematopoietic Stem Cell Transplantation With Reduced Intensity Conditioning, T-Cell Replete Grafts and Post-Transplant Cyclophosphamide In Pediatrics
    Seber, Adriana
    Ginani, Valeria Cortez
    Gouveia, Roseane
    Zecchin, Victor
    Barros, Daniele Porto
    Ibanez, Adriane
    Ribeiro, Leticia Alves
    Felix, Olga Margareth Wanderley Oliveira
    Diniz, Mariane Pereira
    Petrilli, Antonio Sergio
    BLOOD, 2013, 122 (21)
  • [14] T-cell replete haploidentical transplantation with reduced post-transplant cyclophosphamide in six children with infantile osteopetrosis
    Al-Seraihy, Amal
    Al-Saedi, Hawazen
    Al-Ahmari, Ali
    Ghemlas, Ibrahim
    Ayas, Mouhab
    BONE MARROW TRANSPLANTATION, 2021, 56 (07) : 1757 - 1760
  • [15] T-cell replete haploidentical transplantation with reduced post-transplant cyclophosphamide in six children with infantile osteopetrosis
    Amal Al-Seraihy
    Hawazen Al-Saedi
    Ali Al-Ahmari
    Ibrahim Ghemlas
    Mouhab Ayas
    Bone Marrow Transplantation, 2021, 56 : 1757 - 1760
  • [16] Identifying Risk Factors for Acute and Chronic Graft-Versus-Host Disease in TReplete HLA-Haploidentical Hematopoietic Cell Transplantation with Post-Transplant Cyclophosphamide
    Baron, Jimena
    Ridgeway, Michelle
    Zhang, Xu
    Bashey, Asad
    Solomon, Scott R.
    Holland, H. Kent
    Morris, Lawrence E.
    Solh, Melhem M.
    BLOOD, 2017, 130
  • [17] Donor-specific HLA antibodies associate with chronic graft-versus-host disease in haploidentical hematopoietic stem cell transplantation with post-transplant cyclophosphamide
    Carter, Michael
    Taniguchi, Michiko
    Yang, Dongyun
    Arslan, Shukaib
    Shouse, Geoffrey
    Ali, Haris
    Karras, Nicole
    Gendzekhadze, Ketevan
    Al Malki, Monzr M.
    BONE MARROW TRANSPLANTATION, 2022, 57 (01) : 134 - 136
  • [18] Donor-specific HLA antibodies associate with chronic graft-versus-host disease in haploidentical hematopoietic stem cell transplantation with post-transplant cyclophosphamide
    Michael Carter
    Michiko Taniguchi
    Dongyun Yang
    Shukaib Arslan
    Geoffrey Shouse
    Haris Ali
    Nicole Karras
    Ketevan Gendzekhadze
    Monzr M. Al Malki
    Bone Marrow Transplantation, 2022, 57 : 134 - 136
  • [19] Comparison of Outcomes of Haploidentical Peripheral Blood Stem Cell Transplantation with Post-Transplant Cyclophosphamide in Older Versus Younger Patients
    Adoncecchi, Giacomo
    Kumar, Ambuj
    Mogili, Krishnakar
    Faramand, Rawan
    Liu, Hien
    Khimani, Farhad
    Mishra, Asmita
    Nieder, Michael
    Nishihori, Taiga
    Hansen, Doris
    Jain, Michael
    Lazaryan, Aleksandr
    Perez, Lia
    Pidala, Joseph
    Locke, Frederick
    Anasetti, Claudio
    Bejanyan, Nelli
    Elmariah, Hany
    CANCERS, 2025, 17 (02)
  • [20] Comparison of Outcomes of Haploidentical Peripheral Blood Stem Cell Transplantation with Post-Transplant Cyclophosphamide in Older Versus Younger Patients
    Adoncecchi, Giacomo
    Kumar, Ambuj
    Faramand, Rawan
    Liu, Hien D.
    Khimani, Farhad
    Mishra, Asmita
    Nieder, Michael
    Nishihori, Taiga
    Perez, Lia
    Pidala, Joseph
    Anasetti, Claudio
    Bejanyan, Nelli
    Elmariah, Hany
    BLOOD, 2020, 136
12345